Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sequence-dependent cytotoxicity of second-generation oligonucleotides.

Denis Drygin1, Stephen Barone, C Frank Bennett

  • 1Isis Pharmaceuticals, 2292 Faraday Avenue, Carlsbad, CA 92008, USA.

Nucleic Acids Research
|December 18, 2004
PubMed
Summary

Second-generation antisense oligonucleotides (ONs) can inhibit cell proliferation via non-antisense mechanisms. Cytotoxicity is sequence-dependent and linked to lysosomal disruption by aspartic proteases, not apoptosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Naked antisense oligonucleotides remain endolysosomally sequestered despite induced membrane damage.

bioRxiv : the preprint server for biology·2026
Same author

Enhanced splicing modulation by NMA-modified antisense oligonucleotides.

Nucleic acids research·2026
Same author

Pharmacokinetics, Safety, and Tolerability of Anti-miR-17 Oligonucleotide RGLS4326 in Healthy Adult Subjects.

Journal of clinical pharmacology·2026
Same author

Preclinical evaluation of antisense oligonucleotide therapy in a mouse model of <i>HNRNPH2</i>-related neurodevelopmental disorder.

Science translational medicine·2026
Same author

Restoring early postnatal synaptic dysregulation rescues motor neuron degeneration in a mouse model of Spinal and Bulbar Muscular Atrophy.

Nature communications·2026
Same author

The nucleobase guanine at the 3'-terminus of oligonucleotide RGLS4326 drives off-target AMPAR inhibition and CNS toxicity.

Nature communications·2025

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oligonucleotide Therapeutics

Background:

  • Second-generation antisense oligonucleotides (ONs) are investigated for therapeutic applications.
  • Non-antisense mechanisms of ONs, including cytotoxicity, require thorough investigation.
  • Understanding ON-induced cytotoxicity is crucial for optimizing drug development and minimizing off-target effects.

Purpose of the Study:

  • To investigate the non-antisense mechanisms by which second-generation antisense oligonucleotides affect cell growth.
  • To identify sequence-dependent factors contributing to ON-induced cytotoxicity.
  • To elucidate the cellular pathways involved in ON-mediated inhibition of cell proliferation.

Main Methods:

  • Evaluation of a series of chimeric 2'-O-(2-methoxy)ethyl/DNA phosphorothioate oligonucleotides (ONs) for cytotoxicity.

Related Experiment Videos

  • Assessment of caspase-3 activation, chromatin condensation, and lactate dehydrogenase release to distinguish between apoptosis and necrosis.
  • Investigation of lysosomal integrity and the role of aspartic proteases, including cathepsin D, in ON-induced cytotoxicity.

    • Main Results:

    • A subset of ONs exhibited cytotoxicity at concentrations relevant to antisense activity.
    • Toxicity was sequence-dependent and influenced by base and backbone modifications.
    • Cytotoxicity was associated with lysosomal disruption and caspase-3 activation secondary to necrosis, not apoptosis.
    • Intracellular delivery was necessary for observed toxicity.
    • Pepstatin A reduced ON cytotoxicity, while cathepsin D-specific ONs did not, indicating a role for other aspartic proteases.

    Conclusions:

    • Second-generation antisense oligonucleotides can inhibit cell proliferation through non-antisense mechanisms.
    • ON-induced cytotoxicity is sequence-dependent and linked to lysosomal disruption mediated by aspartic proteases.
    • Caspase-3 activation is a consequence of necrosis, not apoptosis, and is not required for cell proliferation inhibition by cytotoxic ONs.